mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.009 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |